Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Chinese Patent Office
UBS
Citi
Accenture
Julphar
US Army
McKinsey
Daiichi Sankyo

Generated: December 11, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: NILOTINIB HYDROCHLORIDE

« Back to Dashboard

NILOTINIB HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novartis TASIGNA nilotinib hydrochloride CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation 0078-0526-51 28 CAPSULE in 1 BLISTER PACK (0078-0526-51)
Novartis TASIGNA nilotinib hydrochloride CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation 0078-0526-87 4 BLISTER PACK in 1 CARTON (0078-0526-87) > 28 CAPSULE in 1 BLISTER PACK
Novartis TASIGNA nilotinib hydrochloride CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation 0078-0592-51 28 CAPSULE in 1 BLISTER PACK (0078-0592-51)
Novartis TASIGNA nilotinib hydrochloride CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation 0078-0592-87 4 BLISTER PACK in 1 CARTON (0078-0592-87) > 28 CAPSULE in 1 BLISTER PACK
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Citi
Moodys
Fish and Richardson
QuintilesIMS
Johnson and Johnson
Dow
Covington
Fuji